PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RMD vs. ^SP500TR
Performance
Risk-Adjusted Performance
Drawdowns
Volatility

Correlation

The correlation between RMD and ^SP500TR is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

RMD vs. ^SP500TR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ResMed Inc. (RMD) and S&P 500 Total Return (^SP500TR). The values are adjusted to include any dividend payments, if applicable.

0.00%10,000.00%20,000.00%30,000.00%40,000.00%50,000.00%NovemberDecember2025FebruaryMarchApril
37,777.60%
1,623.78%
RMD
^SP500TR

Key characteristics

Sharpe Ratio

RMD:

0.43

^SP500TR:

0.32

Sortino Ratio

RMD:

0.88

^SP500TR:

0.57

Omega Ratio

RMD:

1.13

^SP500TR:

1.08

Calmar Ratio

RMD:

0.40

^SP500TR:

0.32

Martin Ratio

RMD:

2.05

^SP500TR:

1.43

Ulcer Index

RMD:

7.91%

^SP500TR:

4.19%

Daily Std Dev

RMD:

37.95%

^SP500TR:

18.99%

Max Drawdown

RMD:

-61.60%

^SP500TR:

-55.25%

Current Drawdown

RMD:

-26.17%

^SP500TR:

-13.83%

Returns By Period

In the year-to-date period, RMD achieves a -6.69% return, which is significantly higher than ^SP500TR's -9.83% return. Over the past 10 years, RMD has outperformed ^SP500TR with an annualized return of 12.73%, while ^SP500TR has yielded a comparatively lower 11.70% annualized return.


RMD

YTD

-6.69%

1M

-4.12%

6M

-10.90%

1Y

20.96%

5Y*

6.12%

10Y*

12.73%

^SP500TR

YTD

-9.83%

1M

-6.83%

6M

-9.33%

1Y

6.85%

5Y*

14.73%

10Y*

11.70%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RMD vs. ^SP500TR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RMD
The Risk-Adjusted Performance Rank of RMD is 6969
Overall Rank
The Sharpe Ratio Rank of RMD is 7070
Sharpe Ratio Rank
The Sortino Ratio Rank of RMD is 6565
Sortino Ratio Rank
The Omega Ratio Rank of RMD is 6666
Omega Ratio Rank
The Calmar Ratio Rank of RMD is 7272
Calmar Ratio Rank
The Martin Ratio Rank of RMD is 7474
Martin Ratio Rank

^SP500TR
The Risk-Adjusted Performance Rank of ^SP500TR is 6969
Overall Rank
The Sharpe Ratio Rank of ^SP500TR is 6565
Sharpe Ratio Rank
The Sortino Ratio Rank of ^SP500TR is 6666
Sortino Ratio Rank
The Omega Ratio Rank of ^SP500TR is 6767
Omega Ratio Rank
The Calmar Ratio Rank of ^SP500TR is 7272
Calmar Ratio Rank
The Martin Ratio Rank of ^SP500TR is 7575
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RMD vs. ^SP500TR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and S&P 500 Total Return (^SP500TR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for RMD, currently valued at 0.43, compared to the broader market-2.00-1.000.001.002.003.00
RMD: 0.43
^SP500TR: 0.32
The chart of Sortino ratio for RMD, currently valued at 0.88, compared to the broader market-6.00-4.00-2.000.002.004.00
RMD: 0.88
^SP500TR: 0.57
The chart of Omega ratio for RMD, currently valued at 1.13, compared to the broader market0.501.001.502.00
RMD: 1.13
^SP500TR: 1.08
The chart of Calmar ratio for RMD, currently valued at 0.40, compared to the broader market0.001.002.003.004.00
RMD: 0.40
^SP500TR: 0.32
The chart of Martin ratio for RMD, currently valued at 2.05, compared to the broader market-5.000.005.0010.0015.0020.00
RMD: 2.05
^SP500TR: 1.43

The current RMD Sharpe Ratio is 0.43, which is higher than the ^SP500TR Sharpe Ratio of 0.32. The chart below compares the historical Sharpe Ratios of RMD and ^SP500TR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00NovemberDecember2025FebruaryMarchApril
0.43
0.32
RMD
^SP500TR

Drawdowns

RMD vs. ^SP500TR - Drawdown Comparison

The maximum RMD drawdown since its inception was -61.60%, which is greater than ^SP500TR's maximum drawdown of -55.25%. Use the drawdown chart below to compare losses from any high point for RMD and ^SP500TR. For additional features, visit the drawdowns tool.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-26.17%
-13.83%
RMD
^SP500TR

Volatility

RMD vs. ^SP500TR - Volatility Comparison

The current volatility for ResMed Inc. (RMD) is 11.09%, while S&P 500 Total Return (^SP500TR) has a volatility of 13.59%. This indicates that RMD experiences smaller price fluctuations and is considered to be less risky than ^SP500TR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
11.09%
13.59%
RMD
^SP500TR
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab